{"title":"Les angiœdème héréditaires de type III : nouvelle maladie ou nouveau diagnostic ?","authors":"L. Bouillet","doi":"10.1016/j.allerg.2008.01.001","DOIUrl":null,"url":null,"abstract":"<div><p>Type III hereditary angiœdema (HAE) presents the same symptoms as type I and type II ones, which are associated with C1Inh deficiency. Women are principally affected. First symptoms often appear during pregnancies or with women taking combined pills. C1Inh and C4 assays are normal. Some of type III HAE can be associated with mutations of the Hageman factor gene. Type III HAE diagnosis is difficult. Kininogenase activity assay and the Hageman factor gene analysis will help us in the future. Treatment strategy is not known: tranexamic acid could be used. Also, C1Inh concentrate could be administrated for laryngeal attacks.</p></div>","PeriodicalId":92953,"journal":{"name":"Revue francaise d'allergologie et d'immunologie clinique","volume":"48 3","pages":"Pages 155-158"},"PeriodicalIF":0.0000,"publicationDate":"2008-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.allerg.2008.01.001","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue francaise d'allergologie et d'immunologie clinique","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S033574570800021X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Type III hereditary angiœdema (HAE) presents the same symptoms as type I and type II ones, which are associated with C1Inh deficiency. Women are principally affected. First symptoms often appear during pregnancies or with women taking combined pills. C1Inh and C4 assays are normal. Some of type III HAE can be associated with mutations of the Hageman factor gene. Type III HAE diagnosis is difficult. Kininogenase activity assay and the Hageman factor gene analysis will help us in the future. Treatment strategy is not known: tranexamic acid could be used. Also, C1Inh concentrate could be administrated for laryngeal attacks.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
